Rajiv Sawant

Rajiv Sawant has a strong background in medicinal chemistry and small molecule drug discovery programs. Rajiv began their career as a Research Assistant at the National Chemical Laboratory in 2003 and continued in a similar role until 2005. In 2010, Rajiv joined Sai Life Sciences Ltd as a Senior Research Associate, where they worked on challenging chemistry in early-stage drug discovery programs and managed a team of scientists. Rajiv then pursued their postdoctoral research at Uppsala University from 2011 to 2012, focusing on diversity-oriented syntheses and the synthesis of 3,4-Dihydroquinazolinones. In their subsequent postdoctoral role at Uppsala University from 2013 to 2015, they developed novel strategies for synthesizing diverse libraries of 3,4-Dihydroquinazolinones and screened selected compounds for anticancer activity. Since 2015, Rajiv has been working at Beactica Therapeutics, initially as a Research Scientist and currently as a Senior Research Scientist. In this role, they are responsible for managing both internal and external synthetic and medicinal chemistry efforts, contributing significantly to hit-to-lead generation and lead optimization, and synthesizing novel small molecules and reference compounds.

From 2006 to 2010, Rajiv Sawant pursued a Ph.D in Organic Chemistry at Savitribai Phule Pune University.